Blog posts

My one WISH this Christmas – ending the stigma around mental health

People holding hands

It’s December, sweaters brandishing pompoms and sparkles are being obnoxiously paraded around offices, the scent of mulled wine and roasted chestnuts oozes from street corners, and that nostalgic Coca-Cola advert is back on television. These can only mean one thing: Christmas is just around the corner.

For many of us, this is an exciting and eagerly-awaited time of year that brings happiness, closeness and reconciliation. While for others, the festive season and the stresses and strains that accompany it is a recipe for mental ill health, and can exacerbate conditions such as anxiety and depression.

So as feelings and festivities grow, we can use this time as an opportunity to reflect, consider others and think about what needs to be done to improve mental wellbeing. Not just at Christmas, but to bring forward a brighter future for all people affected by mental illness.

To make a start, the Institute of Global Health Innovation (IGHI) spoke to one of our scientific advisors, Mr Hutan Ashrafian, who shared his thoughts and expertise on this complex subject.

Why can this time of year take a toll on people’s mental wellbeing?

“One of the main reasons is that loneliness becomes accentuated in people who are already lonely. Their feelings of loneliness become heightened for reasons such as the media coverage of togetherness and family time, people being happy, sharing presents. There’s a societal expectation that everyone will, by definition, be happy. It’s almost inflexible to people being sad or suffering from depression and loneliness.”

Do you think more needs to be done to raise awareness of mental health – not just at Christmas but more broadly?

“It’s a heart-wrenching concept that we stigmatise the source of the biggest loss of “healthy” life years in our society – mental health. Recent reports have shown that the global burden of mental health is increasing, with around 4% of people affected by depression and 3.6% by anxiety. The worldwide cost is in the order of a trillion dollars, yet only around 1-6% of all healthcare spend is on mental health. So ultimately yes, it’s a persistent problem that’s stuck under the carpet, and one that we recently highlighted in our report on anxiety and depression from the World Innovation Summit for Health.

“At this event, the most decorated Olympian of all time, Michael Phelps, gave a talk where he discussed how despite his success, he experienced some very tough times of mental ill health and found it very hard to open up to people. This exemplifies that people from all professions, backgrounds and age groups can suffer from mental health problems, yet research shows that in many countries it’s still massively stigmatised.”

What can we do to get mental health higher on the agenda, then?

“We need to destigmatise and have an open society where people can freely talk. But to get mental health higher on the priority list, there needs to be a greater understanding of the fact that it is such a huge source of disability. Just because it affects the brain, that doesn’t make it any less real than any other diseases.

“In fact, many illnesses come hand in hand with mental health issues, which shows that mental health should get equal attention. So much of the money that’s being put towards certain diseases could also be packaged to cover the mental health problems that can accompany them.”

But it’s not just down to governments, healthcare workers and policy-makers; how can we help those around us?

“Most of our day-to-day interactions happen at school or at work, so the onus is also on schools and industries to think about their environment so that pupils and staff are equipped to look out for one another. Sometimes colleagues know one another better than certain family members, so it’s something we shouldn’t take for granted.

“And support doesn’t need to be extreme; it could start with informal meetings such as chats with friends or colleagues, and then escalate if necessary to more formal counselling or psychiatric treatment. This is called stepped care, and it’s one major thing we highlighted in our WISH report.

“Another brilliant example is called task-sharing, which was made famous recently by Zimbabwe’s ‘friendship bench’ initiative. Trained elderly people would sit on benches and people could come and talk to them about their problems, and now the idea is opening up in schools where more experienced students and teachers are doing the same. Already there’s evidence that it’s having a positive effect.”

Clearly there’s much to be done, and it will take more than a wave of a magic wand to see much-needed improvements. But if you could have one wish granted this Christmas that could bring positive change for people’s mental health, what would it be?

“If people are having problems with their mental health, or symptoms of mental illness, they should be able to just go and talk to someone about it, at any time. There would be no worry of implications, stigma or judgment.”

Mr Hutan Ashrafian is a Clinical Lecturer in Surgery and IGHI’s Chief Scientific Advisor.

Does access to electronic health records by patients improve quality and safety of care?

By Dr Ana Luisa Neves, Research Fellow at the Imperial NIHR Patient Safety Translational Research Centre.

Over the last decade, incentives to adopt electronic health records have spread worldwide. Electronic health records offer many advantages, including an easier access to centralised health information by healthcare providers, patients and researchers, ultimately leading to a better coordination of patient care, greater efficiency, and better health outcomes. (more…)

A Marginal Call in Breast Cancer

By Mr Daniel Leff, Reader in Breast Surgery, Department of Surgery & Cancer, Faculty of Medicine 
As we move towards the end of Breast Cancer Awareness month, it is important to celebrate the many success of breast cancer research and treatment  – whilst breast cancer may be common, more women than ever before are surviving thanks to earlier diagnosis and an improved understanding of the biology of breast cancer leading to more personalised medicine. That said, we still face major challenges. The one that is on the forefront of my mind is the “margins problem” once called the ‘hidden epidemic of breast cancer’.

(more…)

Keeping the heart healthy in October – Cholesterol Awareness Month

Fruit and vegBy Lily Roberts, Centre Assistant for Centre for Health Policy and Patient Safety Translational Research Centre

As the month of October approaches for 2018, we’re reminded by Heart UK to bring awareness to the risks of having high cholesterol levels.

(more…)

Eliminating Viral Hepatitis: ‘Missing Millions or Missing Billions’

By Professor Mark ThurszProfessor of Hepatology within the Department of Surgery and Cancer, Imperial College London

According to the World Health Organisation it is estimated that 250 million people worldwide are chronically infected with the hepatitis B virus (HBV) and 70 million with the hepatitis C virus (HCV). Untreated, these infections can lead to premature death from cirrhosis and liver cancer; recent statistics suggest that together HBV and HCV are responsible for more deaths than HIV.

(more…)

Improving blood transfusion systems using an evidence-based approach

By Chris Bird, MSc Health Policy student at Imperial College and Project Manager in the System Engagement Programme at NICE

Today mark’s World Blood Donor Day – an event to celebrate and thank volunteers the world over, who generously donate blood to support life-saving care and to raise awareness of the continued need for donations of blood and blood products to support high quality safe care for patients who need it most.

(more…)

Towards safer and more equitable maternal health care

by Ana Luisa Neves, General Practitioner and Research Associate at Imperial NIHR PSTRC

Making motherhood safe is a human rights imperative. In the last 20 years, a steady decline has been observed in maternal mortality rates worldwide, but much more needs to be done: nearly 300,000 women still die every year because of pregnancy or childbirth-related complications (1). This means that a mother dies every two minutes.

(more…)

From Flatbush New York to London, via Paris: Ketosis-prone type 2 diabetes, a distinct form of diabetes we’re only beginning to understand

By Dr Shivani MisraHonorary Clinical Research Fellow, Faculty of MedicineDepartment of Medicine

SugarThis Diabetes Week, it’s important to remember that there are more than just two types of diabetes and how global insights into ethnic-specific types can benefit local people with diabetes.

(more…)

New asthma treatment candidate provides hope to millions

By IGHI guest blogger Chanice Henry, Pharma IQ

Researchers have uncovered a new drug candidate that could relieve millions of people who are under-served by current asthma treatments.  

Asthma is a relatively common disease that hinders the respiration of over 300 million individuals globally, leading to episodes of wheezing, chest tightness and other severe problems.

Limitations

Indeed inhalers and other medications exist to manage the disease. However, many of these manufactured treatments have critical side effects and fail to provide relief for around one-third of asthma suffers. Bronchodilator inhalers are used by the majority of asthma suffers and although effective in treating respiratory conditions there are still some gaps in understanding on how and why these inhalers work.

According to recent reports US prices for biologics that combat asthma are to be reviewed this year.

Read more: Biosimilars grow from strength to strength

New hope

After examining over 6,000 compounds, researchers from Rutgers New Jersey Medical School and Shanghai University in China have identified a new drug that relaxes the muscles and opens airways in egg and dust mite induced asthma sufferers.

Luis Ulloa, a lead author and immunologist at Rutgers New Jersey Medical School notes that the treatment could provide hope for asthma suffers without many options currently.

The study discovered that asthmatic lung tissue had lower levels of the protein metallothionein-2 (MT2). In fact, mice without this protein were twice as vulnerable to asthma. Treatment with MT2 improved breathing troubles.

The treatment the researchers developed from the M2-2 protein (TSG12) was found to relax airway muscle cells, widen pulmonary airways and lower pulmonary resistance.

The next stage for the candidate, which is not toxic to human cells and more successful in reducing pulmonary resistance than other FDA approved medications according to the medical school, is for it to enter clinical trials.

Luis Ulloa said: “We found that the TSG12 used in the study is both non-toxic and more effective in reducing pulmonary resistance and could be a promising therapeutic approach for treating asthma without losing their effectiveness overtime.”

Read more: Artificial Intelligence and The Future of Drug Discovery (more…)

Launching the NHS Digital Academy

By Rachel Dunscombe, CEO, NHS Digital Academy

Standing in the Royal Society on the 16th of April waiting for the participants to arrive was both surreal and exciting. Surreal because of the rapid journey our wonderful team had taken to make the programme happen – this had become a reality so quickly. Exciting because I couldn’t wait to get started – this programme is important for the system and for me something I am hugely committed to.

The Digital Academy operational team, of which I am a part, are all keen to ensure that this programme is as grounded in digital leaders’ practice as much as possible rather than being too high end academic. It is a difficult juggling act given that folk will be coming away with a postgraduate diploma from Imperial College London. We worked hard to strike this balance in the run up to the first three day residential.

I set the tone for day one by conducting a poll of the audience. We found out who was in the room and that out of 104 participants there were 53 doctors – the majority by a long way. I do question why more people from other professional groups didn’t apply for the first programme? It would be great to see more nurses, for example, applying for future cohorts given that they represent the majority of the workforce. That said, we do have six nurses on the current cohort along with four pharmacists, a dentist and a social care digital specialist.

Everyone was super enthusiastic and really got stuck in to the icebreaker session. We immediately started to find common ground and get motivated about being a huge movement of like-minded digital leaders. #digitalleaders soon began trending on Twitter followed later by #cohort1. (more…)